InvestorsHub Logo
Followers 118
Posts 20260
Boards Moderated 0
Alias Born 06/13/2011

Re: mrmainstreet post# 31203

Sunday, 07/27/2014 4:02:01 PM

Sunday, July 27, 2014 4:02:01 PM

Post# of 424006
Mrmain

One quick comment re NEJM articles and the role of APOC3.

Amarin announced 4/8/13 that Vascepa lowered APOc3 levels by 25% in Marine and 19.2% in Anchor ...so the recent articles support a positive outcome for RI .

Dr Nissen ( Cleveland Clinic ) is also on record as saying the data supports his trial and RI showing clinical benefit.

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News